Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model
Abstract
1. Introduction
2. Materials and Methods
2.1. Data and Sampling Procedures
2.2. Estimated Models
3. Results
3.1. Selected Demographic Characteristics of the Respondents
3.2. Compliance with COVID-19 Preventive Behaviours and Computed Indicators
3.3. Determinants of Contact-Prevention and Immune System-Boosting Compliance
3.4. Determinants of Willingness to Take COVID-19 Vaccines
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Ministry of Health. First Case of Coronavirus Disease Confirmed in Kenya. Available online: https://www.health.go.ke/first-case-of-coronavirus-disease-confirmed-in-kenya/ (accessed on 22 July 2021).
- Ministry of Health. National Emergency Response Committee on Coronavirus Update on COVID-19 in the Country and Response Measures, as at 26 October 2021. Available online: https://www.health.go.ke/wp-content/uploads/2021/10/Press-Statement-on-Covid-19-26th-October-2021.pdf (accessed on 27 October 2021).
- COVID Live Update: 217,920,243 Cases and 4,524,009 Deaths from the Coronavirus—Worldometer. Available online: https://www.worldometers.info/coronavirus/ (accessed on 31 August 2021).
- Ogunleye, O.O.; Basu, D.; Mueller, D.; Sneddon, J.; Seaton, R.A.; Yinka-Ogunleye, A.F.; Wamboga, J.; Miljković, N.; Mwita, J.C.; Rwegerera, G.M.; et al. Response to the Novel Corona Virus (COVID-19) pandemic across Africa: Successes, challenges, and implications for the future. Front. Pharmacol. 2020, 11, 1205. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Pinchoff, J.; Austrian, K.; Rajshekhar, N.; Abuya, T.; Kangwana, B.; Ochako, R.; Tidwell, J.B.; Mwanga, D.; Muluve, E.; Mbushi, F.; et al. Gendered economic, social and health effects of the COVID-19 pandemic and mitigation policies in Kenya: Evidence from a prospective cohort survey in Nairobi informal settlements. BMJ Open 2021, 11, e042749. [Google Scholar] [CrossRef] [Scilit]
- Pandey, K. COVID-19 in Africa: Nearly Half the Nations Going through Deadlier 3rd Wave. 2021. Available online: https://www.downtoearth.org.in/news/africa/covid-19-in-africa-nearly-half-the-nations-going-through-deadlier-3rd-wave-77986 (accessed on 23 July 2021).
- World Bank. Socioeconomic Impacts of COVID-19 in Kenya on Households: Rapid Response Phone Survey, Round 1. 2021. Available online: https://openknowledge.worldbank.org/handle/10986/35173 (accessed on 30 September 2021).
- United Nations. COVID-19: Africa ‘Third Wave’ Not Yet Over, while Vaccine Inequity Threatens All. 2021. Available online: https://news.un.org/en/story/2021/07/1096252 (accessed on 25 July 2021).
- Mwai, P. Coronavirus in Africa: Concern Grows Over Third Wave of Infection. 2021. Available online: https://www.bbc.com/news/world-africa-53181555 (accessed on 28 July 2021).
- Wako, A. Kenya: COVID-19—As Fourth Wave Spreads, Nairobians Let Down Their Guard. 2021. Available online: https://allafrica.com/stories/202107130906.html. (accessed on 28 July 2021).
- Hampton, L.; Graham-Rowe, D. How Do You Stop a Pandemic? 2020. Available online: https://www.gavi.org/vaccineswork/how-do-you-stop-pandemic (accessed on 18 April 2020).
- World Health Organisation. Overview of Public Health and Social Measures in the Context of COVID-19. 2020. Available online: https://www.who.int/publications/i/item/overview-of-public-health-andsocial-measures-in-the-context-of-covid-19 (accessed on 30 September 2021).
- Opanga, S.A.; Rizvi, N.; Wamaitha, A.; Sefah, I.A.; Godman, B. Availability of medicines in community pharmacy to manage patients with COVID-19 in Kenya; pilot study and implications. SAJP 2021, 10, 36–42. [Google Scholar] [CrossRef] [Scilit]
- Monye, I.; Adelowo, A.B. Strengthening immunity through healthy lifestyle practices: Recommendations for lifestyle interventions in the management of COVID-19. Lifestyle Med. 2020, 1, e7. [Google Scholar] [CrossRef] [Scilit]
- Rachul, C.; Marcon, A.R.; Collins, B.; Caulfield, T. COVID-19 and ‘Immune Boosting’ on the internet: A content analysis of Google Search results. BMJ Open 2020, 10, e040989. [Google Scholar] [CrossRef] [Scilit]
- Kumar, P.; Kumar, M.; Bedi, O.; Gupta, M.; Kumar, S.; Jaiswal, G.; Rahi, V.; Yedke, N.G.; Bijalwan, A.; Sharma, S.; et al. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology 2021, 29, 1–16. [Google Scholar] [CrossRef] [Scilit]
- Patterson, T.; Isales, C.M.; Fulzele, S. Low level of Vitamin C and dysregulation of Vitamin C transporter might be involved in the severity of COVID-19 infection. Aging Dis. 2021, 12, 14–26. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Derbyshire, E.; Delange, J. COVID-19: Is there a role for immunonutrition, particularly in the over 65s? BMJ Nutr. Prev. Health 2020, 3, 100–105. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Prompetchara, E.; Ketloy, C.; Palaga, T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 2020, 38, 1–9. [Google Scholar] [CrossRef] [Scilit]
- Shakoor, H.; Feehan, J.; Mikkelsen, K.; Al Dhaheri, A.S.; Ali, H.I.; Platat, C.; Ismail, L.C.; Stojanovska, L.; Apostolopoulos, V. Be well: A potential role for Vitamin B in COVID-19. Maturitas 2021, 144, 108–111. [Google Scholar] [CrossRef] [Scilit]
- Martineau, A.R.; Jolliffe, D.A.; Hooper, R.L.; Greenberg, L.; Aloia, J.F.; Bergman, P.; Dubnov-Raz, G.; Esposito, S.; Ganmaa, D.; Ginde, A.A.; et al. Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ 2017, 356, i6583. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gombart, A.F.; Pierre, A.; Maggini, S. A Review of micronutrients and the immune system–Working in harmony to reduce the risk of infection. Nutrients 2020, 12, 236. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Machado, P.R.L.; Araújo, M.I.A.S.; Carvalho, L.; Carvalho, E.M. Immune response mechanisms to infections. An. Bras. Dermatol. 2004, 79, 647–664. [Google Scholar] [CrossRef] [Scilit]
- Rouse, B.T.; Sehrawat, S. Immunity and immunopathology to viruses: What decides the outcome? Nat. Rev. Immunol. 2010, 10, 514–526. [Google Scholar] [CrossRef] [Scilit]
- Liu, B.; Li, M.; Zhou, Z.; Guan, X.; Xiang, Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J. Autoimmun. 2020, 111, 102452. [Google Scholar] [CrossRef] [Scilit]
- Sheybani, Z.; Dokoohaki, M.H.; Negahdaripour, M.; Dehdashti, M.; Zolghadr, H.; Moghadami, M.; Masoompour, S.M.; Zolghadr, A.R. The role of folic acid in the management of respiratory disease caused by COVID-19. ChemRxiv 2020. [Google Scholar] [CrossRef]
- Mehmel, M.; Jovanović, N.; Spitz, U. Nicotinamide Riboside—The current state of research and therapeutic uses. Nutrientes 2020, 12, 1616. [Google Scholar] [CrossRef] [Scilit]
- Kumar, V.; Kancharla, S.; Jena, M.K. In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19. VirusDisease 2021, 32, 29–37. [Google Scholar] [CrossRef] [Scilit]
- Calder, P.C. Nutrition, immunity and COVID-19. BMJ Nutr. Prev. Health 2020, 3, 74–92. [Google Scholar] [CrossRef] [Scilit]
- Calder, P.C.; Carr, A.C.; Gombart, A.F.; Eggersdorfer, M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients 2020, 12, 1181. [Google Scholar] [CrossRef] [Scilit]
- Kashiouris, M.G.; L’Heureux, M.; Cable, C.A.; Fisher, B.J.; Leichtle, S.W.; Fowler, A.A. The emerging role of Vitamin C as a treatment for Sepsis. Nutrients 2020, 12, 292. [Google Scholar] [CrossRef] [Scilit]
- OECD. Enhancing Public Trust in COVID-19 Vaccination: The Role of Governments. OECD Policy Responses to Coronavirus (COVID-19). 2021. Available online: https://www.oecd.org/coronavirus/policy-responses/enhancing-public-trust-in-covid-19-vaccination-the-role-of-governments-eae0ec5a/ (accessed on 28 July 2021).
- Ezeh, A.; Oyebode, O.; Satterthwaite, D.; Chen, Y.-F.; Ndugwa, R.; Sartori, J.; Mberu, B.; Melendez-Torres, G.J.; Haregu, T.N.; Watson, S.I.; et al. The history, geography, and sociology of slums and the health problems of people who live in slums. Lancet 2017, 389, 547–558. [Google Scholar] [CrossRef] [Scilit]
- Ministry of Health. National Policy Guidelines on Immunization 2013. Available online: http://e-cavi.com/wp-content/uploads/2014/11/KENYA-NATIONAL-POLICY-ON-IMMUNIZATION-2013.pdf (accessed on 2 August 2021).
- Larson, H.J.; Schulz, W.S.; Tucker, J.D.; Smith, D.M.D. Measuring vaccine confidence: Introducing a global vaccine confidence index. PLoS Curr. 2015, 7, ecurrents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4. [Google Scholar] [CrossRef] [Scilit]
- De Figueiredo, A.; Simas, C.; Karafillakis, E.; Paterson, P.; Larson, H.J. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: A large-scale retrospective temporal modelling study. Lancet 2020, 396, 898–908. [Google Scholar] [CrossRef] [Scilit]
- Machingaidze, S.; Wiysonge, C.S. Understanding COVID-19 vaccine hesitancy. Nat. Med. 2021, 27, 1338–1339. [Google Scholar] [CrossRef] [Scilit]
- Wiysonge, C.S.; Ndwandwe, D.; Ryan, J.; Jaca, A.; Batouré, O.; Anya, B.-P.M.; Cooper, S. Vaccine hesitancy in the era of COVID-19: Could lessons from the past help in divining the future? Hum. Vaccin. Immunother. 2021, 8, 1–3. [Google Scholar] [CrossRef] [Scilit]
- Saied, S.M.; Saied, E.M.; Kabbash, I.A.; Abdo, S.A.E. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J. Med. Virol. 2021, 93, 4280–4291. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2021, 27, 225–228. [Google Scholar] [CrossRef] [Scilit]
- Sallam, M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- World Health Organization. Available online: https://apps.who.int/gb/ebwha/pdf_fles/WHA73/A73_R1-en.pdf (accessed on 19 May 2020).
- Ong, S.W.X.; Young, B.E.; Lye, D.C. Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes. Lancet Infect. Dis. 2021, 21, 1195–1197. [Google Scholar] [CrossRef] [Scilit]
- SARS-CoV-2 Variants: The Need for Urgent Public Health Action beyond Vaccines. Available online: https://covid19commission.org/public-health-measures (accessed on 30 September 2021).
- Gibson, D.G.; Ochieng, B.; Kagucia, E.W.; Were, J.; Hayford, K.; Moulton, L.H.; Levine, O.S.; Odhiambo, F.; O’Brien, K.; Feikin, D.R. Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): A cluster randomised controlled trial. Lancet Glob. Heal. 2017, 5, e428–e438. [Google Scholar] [CrossRef] [Scilit]
- Valenti, G.D.; Faraci, P. Identifying predictive factors in compliance with the COVID-19 containment measures: A mediation analysis. Psychol. Res. Behav. Manag. 2021, 14, 1325–1338. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Deeks, A.; Lombard, C.; Michelmore, J.; Teede, H. The effects of gender and age on health related behaviors. BMC Public Health 2009, 9, 213. [Google Scholar] [CrossRef]
- Vaidya, V.; Partha, G.; Karmakar, M. Gender differences in utilization of preventive care services in the United States. J. Women’s Health 2012, 21, 140–145. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Orangi, S.; Pinchoff, J.; Mwanga, D.; Abuya, T.; Hamaluba, M.; Warimwe, G.; Austrian, K.; Barasa, E. Assessing the level and determinants of COVID-19 vaccine confidence in Kenya. Vaccines 2021, 9, 936. [Google Scholar] [CrossRef] [Scilit]
- Chen, T.; Dai, M.; Xia, S.; Zhou, Y. Do messages matter? Investigating the combined effects of framing, outcome uncertainty, and number format on COVID-19 vaccination attitudes and intention. Health Commun. 2021, 1–8. [Google Scholar] [CrossRef] [Scilit]
- Chen, M.; Li, Y.; Chen, J.; Wen, Z.; Feng, F.; Zou, H.; Fu, C.; Chen, L.; Shu, Y.; Sun, C. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum. Vaccines Immunother. 2021, 17, 2279–2288. [Google Scholar] [CrossRef] [Scilit]
- McAbee, L.; Tapera, O.; Kanyangarara, M. Factors associated with COVID-19 vaccine intentions in Eastern Zimbabwe: A cross-sectional study. Vaccines 2021, 9, 1109. [Google Scholar] [CrossRef] [Scilit]
- Al-Mohaithef, M.; Padhi, B.K. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: A web-based national survey. J. Multidiscip. Health 2020, 13, 1657–1663. [Google Scholar] [CrossRef] [Scilit]
- Coustasse, A.; Kimble, C.; Maxik, K. COVID-19 and vaccine hesitancy. J. Ambul. Care Manag. 2021, 44, 71–75. [Google Scholar] [CrossRef] [Scilit]
- Wang, J.; Jing, R.; Lai, X.; Zhang, H.; Lyu, Y.; Knoll, M.D.; Fang, H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines 2020, 8, 482. [Google Scholar] [CrossRef] [Scilit]
- Lin, C.; Tu, P.; Beitsch, L.M. Confidence and receptivity for COVID-19 vaccines: A rapid systematic review. Vaccines 2020, 9, 16. [Google Scholar] [CrossRef] [Scilit]
- Hursh, S.R.; Strickland, J.C.; Schwartz, L.P.; Reed, D.D. Quantifying the impact of public perceptions on vaccine acceptance using behavioral economics. Front. Public Health 2020, 8, 608852. [Google Scholar] [CrossRef] [Scilit]
- Bell, S.; Clarke, R.; Mounier-Jack, S.; Walker, J.L.; Paterson, P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 2021, 38, 7789–7798. [Google Scholar] [CrossRef] [Scilit]
- Robles, A.S.; Gallahue, A.; Bennett, S.; Nerida, T.; Larson, T.; Parker, H.; Riddle, M. Determinants of COVID-19 vaccine acceptance among health care providers and citizens in Nevada. J. Investig. Med. 2021, 69, 235. [Google Scholar]
- Nguyen, K.H.; Srivastav, A.; Razzaghi, H.; Williams, W.; Lindley, M.C.; Jorgensen, C.; Abad, N.; Singleton, J.A. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination—United States, september and december 2020. Morb. Mortal. Wkly. Rep. 2021, 70, 217–222. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Guidry, J.P.; Laestadius, L.I.; Vraga, E.K.; Miller, C.A.; Perrin, P.B.; Burton, C.W.; Ryan, M.; Fuemmeler, B.F.; Carlyle, K.E. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am. J. Infect. Control. 2021, 49, 137–142. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Betsch, C.; Schmid, P.; Heinemeier, D.; Korn, L.; Holtmann, C.; Bohm, R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE 2018, 13, e0208601. [Google Scholar] [CrossRef] [Scilit]
- Thomson, A.; Robinson, K.; Vallée-Tourangeau, G. The 5As: A practical taxonomy for the determinants of vaccine uptake. Vaccine 2016, 34, 1018–1024. [Google Scholar] [CrossRef] [Scilit]
- Dryhurst, S.; Schneider, C.R.; Kerr, J.; Freeman, A.L.J.; Recchia, G.; van der Bles, A.M.; Spiegelhalter, D.; van der Linden, S. Risk perceptions of COVID-19 around the world. J. Risk Res. 2020, 23, 994–1006. [Google Scholar] [CrossRef] [Scilit]
- Kwok, K.O.; Li, K.K.; Chan, H.H.H.; Yi, Y.Y.; Tang, A.; Wei, W.I.; Wong, S.Y.S. Community responses during early phase of COVID-19 epidemic, Hong Kong. Emerg. Infect. Dis. 2020, 26, 1575–1579. [Google Scholar] [CrossRef] [Scilit]
- Wise, T.; Zbozinek, T.D.; Michelini, G.; Hagan, C.C.; Mobbs, D. Changes in risk perception and self-reported protective behaviour during the first week of the COVID-19 pandemic in the United States. R. Soc. Open Sci. 2020, 7, 7. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Janz, N.K.; Becker, M.H. The health belief model: A decade later. Health Educ. Q. 1984, 11, 1–47. [Google Scholar] [CrossRef] [Scilit]
- Rogers, R.W. Cognitive and Physiological Processes in Fear Appeals and Attitude Change: A Revised Theory of Protection Motivation; Cacioppo, J., Petty, R., Eds.; Social Psychophysiology: New York, NY, USA, 1983. [Google Scholar]
- Dror, A.A.; Eisenbach, N.; Taiber, S.; Morozov, N.G.; Mizrachi, M.; Zigron, A.; Srouji, S.; Sela, E. Vaccine hesitancy: The next challenge in the fight against COVID-19. Eur. J. Epidemiol. 2020, 35, 775–779. [Google Scholar] [CrossRef] [Scilit]
- Graffigna, G.; Palamenghi, L.; Boccia, S.; Barello, S. Relationship between citizens’ health engagement and intention to take the COVID-19 vaccine in Italy: A mediation analysis. Vaccines 2020, 8, 576. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Detoc, M.; Bruel, S.; Frappe, P.; Tardy, B.; Botelho-Nevers, E.; Gagneux-Brunon, A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine 2020, 38, 7002–7006. [Google Scholar] [CrossRef] [Scilit]
- Pape, U.J.; Sinha, N.; Delius, A.J.S. Kenya COVID-19 Rapid Response Phone Survey Households 2020–2021, Panel. Available online: https://microdata.worldbank.org/index.php/catalog/3774 (accessed on 15 August 2021).
- Jolliffe, I.T.; Cadima, J. Principal component analysis: A review and recent developments. Phil. Trans. R. Soc. A 2016, 374, 20150202. [Google Scholar] [CrossRef] [Scilit]
- Jaadi, Z. A Step-by-Step Explanation of Principal Component Analysis. Available online: https://builtin.com/data-science/step-step-explanation-principal-component-analysis (accessed on 23 July 2021).
- StataCorp. Xtprobit—Random-Effects and Population-Averaged Probit Models. Available online: https://www.stata.com/manuals/xtxtprobit.pdf (accessed on 22 September 2021).
- Wooldridge, J.M. Introductory Econometrics: A Modern Approach, 5th ed.; Centage Learning: Boston, MA, USA, 2012. [Google Scholar]
- Kollamparambil, U.; Oyenubi, A. Behavioural response to the COVID-19 pandemic in South Africa. PLoS ONE 2021, 16, e0250269. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Petherick, A.; Goldszmidt, R.; Andrade, E.B.; Furst, R.; Hale, T.; Pott, A.; Wood, A. A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue. Nat. Hum. Behav. 2021, 5, 1145–1160. [Google Scholar] [CrossRef] [Scilit]
- Saketkhoo, K.; Januszkiewicz, A.; Sackner, M. Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest 1978, 74, 408–410. [Google Scholar] [CrossRef] [Scilit]
- Arreola, R.; Quintero-Fabian, S.; López-Roa, R.I.; Flores-Gutiérrez, E.O.; Reyes, J.P.; Carrera-Quintanar, L.; Ortuño-Sahagún, D. Immunomodulation and anti-inflammatory effects of garlic compounds. J. Immunol. Res. 2015, 2015, 1–13. [Google Scholar] [CrossRef] [Scilit]
- Shimizu, C.; Wakita, Y.; Inoue, T.; Hiramitsu, M.; Okada, M.; Mitani, Y.; Segawa, S.; Tsuchiya, Y.; Nabeshima, T. Effects of lifelong intake of lemon polyphenols on aging and intestinal microbiome in the senescence-accelerated mouse prone 1 (SAMP1). Sci. Rep. 2019, 9, 3671. [Google Scholar] [CrossRef] [Scilit]
- Amado, D.A.V.; Bet Helmann, G.A.; Detoni, A.M.; De Carvalho, S.L.C.; De Aguiar, C.M.; Martin, C.A.; Tiuman, T.S.; Cottica, S.M. Antioxidant and antibacterial activity and preliminary toxicity analysis of four varieties of avocado (Persea americana Mill.). Braz. J. Food Technol. 2019, 22, 2018044. [Google Scholar] [CrossRef] [Scilit]
- Dodd, R.H.; Cvejic, E.; Bonner, C.; Pickles, K.; McCaffery, K.J.; Ayre, J.; Batcup, C.; Copp, T.; Cornell, S.; Dakin, T.; et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect. Dis. 2021, 21, 318–319. [Google Scholar] [CrossRef] [Scilit]
- Rhodes, A.; Hoq, M.; Measey, M.-A.; Danchin, M. Intention to vaccinate against COVID-19 in Australia. Lancet Infect. Dis. 2021, 21, e110. [Google Scholar] [CrossRef] [Scilit]
- Padidar, S.; Liao, S.-M.; Magagula, S.; Mahlaba, T.A.M.; Nhlabatsi, N.M.; Lukas, S. Assessment of early COVID-19 compliance to and challenges with public health and social prevention measures in the Kingdom of Eswatini, using an online survey. PLoS ONE 2021, 16, e0253954. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Al-Rahimi, J.S.; Nass, N.M.; Hassoubah, S.A.; Wazqar, D.Y.; Alamoudi, S.A. Levels and predictors of fear and health anxiety during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia: A cross-sectional correlational study. PLoS ONE 2021, 16, e0250554. [Google Scholar] [CrossRef] [Scilit]
- Posel, D.; Oyenubi, A.; Kollamparambil, U. Job loss and mental health during the COVID-19 lockdown: Evidence from South Africa. PLoS ONE 2021, 16, e0249352. [Google Scholar] [CrossRef] [Scilit]
- Bendau, A.; Plag, J.; Petzold, M.B.; Ströhle, A. COVID-19 vaccine hesitancy and related fears and anxiety. Int. Immunopharmacol. 2021, 97, 107724. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Perez-Arce, F.; Angrisani, M.; Bennett, D.; Darling, J.; Kapteyn, A.; Thomas, K. COVID-19 vaccines and mental distress. PLoS ONE 2021, 16, e0256406. [Google Scholar] [CrossRef] [Scilit]
- Kejriwal, M.; Shen, K. COVID-19 Vaccine hesitancy is positively associated with affective wellbeing. PsyArXiv 2021. [Google Scholar] [CrossRef] [Scilit]



| Variable | Mean | Std. Dev. | Min | Max |
|---|---|---|---|---|
| Dependent variable | ||||
| Agree to vaccinate (yes = 1, 0 otherwise) | 0.774 | - | 0 | 1 |
| Endogenous regressors | ||||
| Contact-prevention compliance | 1.69 × 10−8 | 1.458 | −1.758 | 5.944 |
| Immune-boosting compliance | −2.12 × 10−8 | 1.370 | −0.519 | 13.270 |
| Exogenous variables | ||||
| Days felt depressed in a week | 0.428 | 0.761 | 0 | 3 |
| Days felt lonely in a week | 0.410 | 0.752 | 0 | 3 |
| Days felt hopeful in a week | 1.272 | 1.274 | 0 | 3 |
| Days of physical reactions—nausea, sweating, breathing problem | 0.298 | 0.668 | 0 | 3 |
| Urban resident (yes = 1, 0 otherwise) | 0.527 | - | 0 | 1 |
| Age of the respondent | 40.014 | 13.822 | 18 | 98 |
| Gender (male) (yes = 1, 0 otherwise) | 0.528 | - | 0 | 1 |
| Household size | 3.793 | 2.118 | 1 | 17 |
| Formal education (yes = 1, 0 otherwise) | 0.975 | - | 0 | 1 |
| Know infected person (yes = 1, 0 otherwise) | 0.051 | - | 0 | 1 |
| Instrumental variables | ||||
| Feeling anxious (yes = 1, 0 otherwise) | 0.556 | - | 0 | 1 |
| Days felt nervous in a week | 0.468 | 0.788 | 0 | 3 |
| COVID-19 Preventive/Immune-Boosting Behaviours | Wave 4 (n = 4867) | Wave 5 (n = 5835) | Both Waves (n = 10,702) | |||
|---|---|---|---|---|---|---|
| Contact Avoidance Attributes | Frequency | % | Frequency | % | Frequency | % |
| Hand-washing | 4346 | 89.30 | 5433 | 93.11 | 9779 | 91.38 |
| Avoiding handshakes | 4392 | 90.24 | 5638 | 96.62 | 10,030 | 93.72 |
| Wearing masks | 3891 | 79.95 | 4719 | 80.87 | 8610 | 80.45 |
| Avoiding groups of more than 10 persons | 3440 | 70.68 | 4766 | 81.68 | 8206 | 76.68 |
| Hand sanitizer | 2477 | 50.89 | 2995 | 51.33 | 5472 | 51.13 |
| Covering mouth if coughing | 1399 | 28.74 | 1568 | 26.87 | 2967 | 27.72 |
| Staying at home more | 1335 | 27.43 | 1376 | 23.58 | 2711 | 25.33 |
| Traveling less | 570 | 11.71 | 422 | 7.23 | 992 | 9.27 |
| Working less | 405 | 8.32 | 365 | 6.26 | 770 | 7.19 |
| Stocking up food at home | 542 | 11.14 | 584 | 10.01 | 1126 | 10.52 |
| Immune-Boosting Attributes | ||||||
| Drinking tea with lemon | 404 | 8.30 | 319 | 5.47 | 723 | 6.76 |
| Drinking warm water | 404 | 8.30 | 600 | 10.28 | 1004 | 9.38 |
| Taking vitamin C rich fruits | 134 | 2.75 | 120 | 2.06 | 254 | 2.37 |
| Eating lemons, garlic, avocadoes, mangoes | 144 | 2.96 | 460 | 7.88 | 604 | 5.64 |
| Eating alkaline foods | 44 | 0.90 | 60 | 1.03 | 104 | 0.97 |
| Taking bicarbonate | 88 | 1.81 | 34 | 0.58 | 122 | 1.14 |
| COVID-19 Contact-Prevention Indicator | Immune System-Boosting Indicator | |||||
|---|---|---|---|---|---|---|
| Component | Eigenvalue | Proportion | Cumulative | Eigenvalue | Proportion | Cumulative |
| Comp1 | 2.03128 | 0.2257 | 0.2257 | 1.87751 | 0.3129 | 0.3129 |
| Comp2 | 1.51467 | 0.1683 | 0.3940 | 1.07646 | 0.1794 | 0.4923 |
| Comp3 | 0.990668 | 0.1101 | 0.5041 | 0.950245 | 0.1584 | 0.6507 |
| Comp4 | 0.928001 | 0.1031 | 0.6072 | 0.858807 | 0.1431 | 0.7938 |
| Comp5 | 0.891516 | 0.0991 | 0.7062 | 0.702411 | 0.1171 | 0.9109 |
| Comp6 | 0.730758 | 0.0812 | 0.7874 | 0.534568 | 1.0000 | |
| Comp7 | 0.662303 | 0.0736 | 0.8610 | |||
| Comp8 | 0.644016 | 0.0716 | 0.9326 | |||
| Comp9 | 0.606791 | 0.0674 | 1.0000 | |||
| 4th Wave | 5th Wave | Both Waves | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variables | Freq | % Willingness | Total | Freq | % Willingness | Total | Freq | % Willingness | Total |
| Age | |||||||||
| <25 | 335 | 71.89 | 466 | 464 | 77.33 | 600 | 799 | 74.95 | 1066 |
| 25<35 | 1047 | 71.13 | 1472 | 1452 | 79.00 | 1838 | 2499 | 75.50 | 3310 |
| 35<45 | 957 | 72.89 | 1313 | 1256 | 82.41 | 1524 | 2213 | 78.00 | 2837 |
| 45<55 | 632 | 77.83 | 812 | 774 | 81.39 | 951 | 1406 | 79.75 | 1763 |
| 55<65 | 349 | 73.94 | 472 | 454 | 83.30 | 545 | 803 | 78.96 | 1017 |
| 65+ | 260 | 78.31 | 332 | 304 | 80.64 | 377 | 564 | 79.55 | 709 |
| Sector | |||||||||
| Rural | 1725 | 75.16 | 2295 | 2203 | 79.70 | 2764 | 3928 | 77.64 | 5059 |
| Urban | 1855 | 72.12 | 2572 | 2501 | 81.44 | 3071 | 4356 | 77.19 | 5643 |
| Gender | |||||||||
| Female | 1687 | 73.06 | 2309 | 2197 | 80.04 | 2745 | 3884 | 76.85 | 5054 |
| Male | 1893 | 74.00 | 2558 | 2507 | 81.13 | 3090 | 4400 | 77.90 | 5648 |
| Education | |||||||||
| None | 109 | 70.78 | 154 | 82 | 70.69 | 116 | 191 | 70.74 | 270 |
| Preprimary | 99 | 63.46 | 156 | 115 | 58.97 | 195 | 214 | 60.97 | 351 |
| Primary | 1286 | 72.53 | 1773 | 1387 | 76.76 | 1807 | 2673 | 74.66 | 3580 |
| Post primary/Vocational | 23 | 79.31 | 29 | 63 | 80.77 | 78 | 86 | 80.37 | 107 |
| Secondary | 1499 | 74.95 | 2000 | 2288 | 83.08 | 2754 | 3787 | 79.66 | 4754 |
| College | 426 | 75.80 | 562 | 640 | 86.37 | 741 | 1066 | 81.81 | 1303 |
| Undergraduate | 119 | 70.83 | 168 | 116 | 89.92 | 129 | 235 | 79.12 | 297 |
| Postgraduate | 19 | 76.00 | 25 | 13 | 86.67 | 15 | 32 | 80.00 | 40 |
| Total | 3580 | 73.56 | 4867 | 4704 | 80.62 | 5835 | 8284 | 77.41 | 10,702 |
| COVID-19 Contact-Prevention Model | Immune System-Boosting Model | |||||
|---|---|---|---|---|---|---|
| Variables | Coef. | Robust Std Error | t Stat | Coef. | Robust Std Error | t Stat |
| Feel Anxious | 0.6949034 *** | 0.0267955 | 25.93 | 0.6239946 *** | 0.0253449 | 24.62 |
| Days depressed | 0.4954908 *** | 0.0343624 | 14.42 | 0.3213363 *** | 0.0313333 | 10.26 |
| Days nervous | −0.2574125 *** | 0.0293624 | −8.77 | −00.0349017 | 0.0301548 | −1.16 |
| Days felt lonely | 0.2634849 *** | 0.0274009 | 9.62 | −00.0553346 ** | 0.0259778 | −2.13 |
| Days felt hopeful | −0.1187308 *** | 0.0108604 | −10.93 | −00.0488207 *** | 0.0102056 | −4.78 |
| Days of physical reactions | 0.1869977 *** | 0.0378865 | 4.94 | −00.071272 ** | 0.0307028 | −2.32 |
| Urban resident | −0.0094086 | 0.0261114 | −0.36 | 0.0006897 | 0.0256915 | 0.03 |
| Age | −0.0000723 | 0.0009683 | −0.07 | 0.0000127 | 0.0009425 | 0.01 |
| Gender (male) | −0.081161 *** | 0.0259716 | −3.12 | −00.0447487 | 0.0256916 | −1.74 |
| Household size | −0.0020518 | 0.0061486 | −0.33 | −00.0082851 | 0.0061396 | −1.35 |
| Formal education | 0.1381852 | 0.079267 | 1.74 | 0.0132153 | 0.0895285 | 0.15 |
| Know infected person | −0.3011192 *** | 0.0571598 | −5.27 | −0.1179174 | 0.0638923 | −1.85 |
| Constant | −0.5513398 *** | 0.0996041 | −5.54 | −0.314684 *** | 0.1058094 | −2.97 |
| Number of observations | 10,702 | 10,702 | ||||
| F(12, 10,689) | 128.21 *** | 67.44 *** | ||||
| R-squared | 0.1640 | 0.0711 | ||||
| Variance Inflation Factor (VIF) | 1.48 | 1.48 | ||||
| Variables | Coef. | Standard Error | Z Statistics |
|---|---|---|---|
| Contact-prevention compliance | −1.610935 *** | 0.2495848 | −6.45 |
| Immune-boosting compliance | 203449 *** | 0.305411 | 6.66 |
| Days felt nervous in a week | −0.3476006 *** | 0.0545842 | −6.37 |
| Days felt lonely in a week | 0.4853005 *** | 0.0937532 | 5.18 |
| Days felt hopeful in a week | −0.0357433 | 0.019011 | −1.88 |
| Days of physical reactions—nausea, sweating, breathing problems | 0.1555594 | 0.0807415 | 1.93 |
| Urban resident | −0.0438994 | 0.0298572 | −1.47 |
| Age of the respondent | 0.0045713 *** | 0.0011037 | 4.14 |
| Gender (male} | 0.0179088 | 0.0301979 | 0.59 |
| Household size | −0.0113539 | 0.0073404 | −1.55 |
| Formal education | 0.4981303 *** | 0.0952476 | 5.23 |
| Know infected person | −0.0993262 | 0.0786707 | −1.26 |
| Error term 1 | 1.502961 *** | 0.2493549 | 6.03 |
| Error term 2 | −1.922836 *** | 0.305118 | −6.30 |
| Constant | 0.1769253 | 0.1235355 | 1.43 |
| lnsig2u | −2.35439 *** | 0.3840399 | |
| Sigma_u | 0.3081418 *** | 0.0591694 | |
| Rho | 0.0867174 *** | 0.030415 | |
| Number of observations | 10,702 | ||
| Integration points | 12 | ||
| Wald chi2(14) | 505.46 *** | ||
| Likelihood-ratio test of rho = 0 | 8.08 *** |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Oyekale, A.S. Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model. Vaccines 2021, 9, 1359. https://doi.org/10.3390/vaccines9111359
Oyekale AS. Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model. Vaccines. 2021; 9(11):1359. https://doi.org/10.3390/vaccines9111359
Chicago/Turabian StyleOyekale, Abayomi Samuel. 2021. "Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model" Vaccines 9, no. 11: 1359. https://doi.org/10.3390/vaccines9111359
APA StyleOyekale, A. S. (2021). Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model. Vaccines, 9(11), 1359. https://doi.org/10.3390/vaccines9111359